Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 17 March 2000: Vol. 287. no. 5460, pp. 1964 - 1969 DOI: 10.1126/science.287.5460.1964
|
|
Review
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Stuart L. Schreiber
Modern drug discovery often involves screening
small molecules for their ability to bind to a preselected protein
target. Target-oriented syntheses of these small molecules,
individually or as collections (focused libraries), can be planned
effectively with retrosynthetic analysis. Drug discovery can also
involve screening small molecules for their ability to modulate a
biological pathway in cells or organisms, without regard for any
particular protein target. This process is likely to benefit in the
future from an evolving forward analysis of synthetic pathways, used in
diversity-oriented synthesis, that leads to structurally complex and
diverse small molecules. One goal of diversity-oriented syntheses is to
synthesize efficiently a collection of small molecules capable of
perturbing any disease-related biological pathway, leading eventually
to the identification of therapeutic protein targets capable of being
modulated by small molecules. Several synthetic planning principles for
diversity-oriented synthesis and their role in the drug discovery
process are presented in this review.
The author is at the Howard Hughes Medical Institute, the
Department of Chemistry and Chemical Biology, and the Harvard Institute
of Chemistry and Cell Biology, Harvard University, Cambridge, MA 02138, USA. E-mail: sls{at}slsiris.harvard.edu
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Systems Diagnostics: The Systems Approach to Molecular Imaging.
- D. Y. Lee and K. C. P. Li (2009)
Am. J. Roentgenol.
193, 287-294
| Abstract »
| Full Text »
| PDF »
- Systematizing Serendipity for Cardiovascular Drug Discovery.
- P. J. Schlueter and R. T. Peterson (2009)
Circulation
120, 255-263
| Full Text »
| PDF »
- Accelerating the Development of Novel Molecular Imaging Probes: A Role for High-Throughput Screening.
- H. C. Manning, A. Lander, E. McKinley, and N. J. Mutic (2008)
J. Nucl. Med.
49, 1401-1404
| Abstract »
| Full Text »
| PDF »
- Identification of Novel Epoxide Inhibitors of Hepatitis C Virus Replication Using a High-Throughput Screen.
- L. F. Peng, S. S. Kim, S. Matchacheep, X. Lei, S. Su, W. Lin, W. Runguphan, W.-H. Choe, N. Sakamoto, M. Ikeda, et al. (2007)
Antimicrob. Agents Chemother.
51, 3756-3759
| Abstract »
| Full Text »
| PDF »
- Molecular Imaging of Cardiovascular Disease.
- F. A. Jaffer, P. Libby, and R. Weissleder (2007)
Circulation
116, 1052-1061
| Full Text »
| PDF »
- Investigation of 3 Industry-Wide Applied Storage Conditions for Compound Libraries.
- P. E. Ilouga, D. Winkler, C. Kirchhoff, B. Schierholz, and J. Wolcke (2007)
J Biomol Screen
12, 21-32
| Abstract »
| PDF »
- Using Aptamers as Capture Reagents in Bead-Based Assay Systems for Diagnostics and Hit Identification.
- P. Porschewski, M. A.-M. Grattinger, K. Klenzke, A. Erpenbach, M. R. Blind, and F. Schafer (2006)
J Biomol Screen
11, 773-781
| Abstract »
| PDF »
- Bestatin, an Inhibitor of Aminopeptidases, Provides a Chemical Genetics Approach to Dissect Jasmonate Signaling in Arabidopsis.
- W. Zheng, Q. Zhai, J. Sun, C.-B. Li, L. Zhang, H. Li, X. Zhang, S. Li, Y. Xu, H. Jiang, et al. (2006)
Plant Physiology
141, 1400-1413
| Abstract »
| Full Text »
| PDF »
- Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications.
- F. A. Jaffer, P. Libby, and R. Weissleder (2006)
J. Am. Coll. Cardiol.
47, 1328-1338
| Abstract »
| Full Text »
| PDF »
- ChemDB: a public database of small molecules and related chemoinformatics resources.
- J. Chen, S. J. Swamidass, Y. Dou, J. Bruand, and P. Baldi (2005)
Bioinformatics
21, 4133-4139
| Abstract »
| Full Text »
| PDF »
- Genetic and chemical analyses of the action mechanisms of sirtinol in Arabidopsis.
- X. Dai, K.-i. Hayashi, H. Nozaki, Y. Cheng, and Y. Zhao (2005)
PNAS
102, 3129-3134
| Abstract »
| Full Text »
| PDF »
- Compound library development guided by protein structure similarity clustering and natural product structure.
- M. A. Koch, L.-O. Wittenberg, S. Basu, D. A. Jeyaraj, E. Gourzoulidou, K. Reinecke, A. Odermatt, and H. Waldmann (2004)
PNAS
101, 16721-16726
| Abstract »
| Full Text »
| PDF »
- From The Cover: Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens.
- S. N. Bailey, D. M. Sabatini, and B. R. Stockwell (2004)
PNAS
101, 16144-16149
| Abstract »
| Full Text »
| PDF »
- Phosphorothioate Di- and Trinucleotides as a Novel Class of Anti-Hepatitis B Virus Agents.
- R. P. Iyer, Y. Jin, A. Roland, J. D. Morrey, S. Mounir, and B. Korba (2004)
Antimicrob. Agents Chemother.
48, 2199-2205
| Abstract »
| Full Text »
| PDF »
- Generating Diverse Skeletons of Small Molecules Combinatorially.
- M. D. Burke, E. M. Berger, and S. L. Schreiber (2003)
Science
302, 613-618
| Abstract »
| Full Text »
| PDF »
- Chemical Genetic Approaches to Plant Biology.
- H. E. Blackwell and Y. Zhao (2003)
Plant Physiology
133, 448-455
| Full Text »
| PDF »
- From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes.
- R. L. Strausberg and S. L. Schreiber (2003)
Science
300, 294-295
| Abstract »
| Full Text »
| PDF »
- Retrovirally Delivered Random Cyclic Peptide Libraries Yield Inhibitors of Interleukin-4 Signaling in Human B Cells.
- T. M. Kinsella, C. T. Ohashi, A. G. Harder, G. C. Yam, W. Li, B. Peelle, E. S. Pali, M. K. Bennett, S. M. Molineaux, D. A. Anderson, et al. (2002)
J. Biol. Chem.
277, 37512-37518
| Abstract »
| Full Text »
| PDF »
- Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries.
- M. Hochgurtel, H. Kroth, D. Piecha, M. W. Hofmann, C. Nicolau, S. Krause, O. Schaaf, G. Sonnenmoser, and A. V. Eliseev (2002)
PNAS
99, 3382-3387
| Abstract »
| Full Text »
| PDF »
- Drowning in the Magic Well: Shaman Pharmaceuticals and the Elusive Value of Traditional Knowledge.
- R. A. Clapp and C. Crook (2002)
The Journal of Environment Development
11, 79-102
| Abstract »
| PDF »
- Profiling Novel Sulfonamide Antitumor Agents with Cell-based Phenotypic Screens and Array-based Gene Expression Analysis.
- A. Yokoi, J. Kuromitsu, T. Kawai, T. Nagasu, N. Hata Sugi, K. Yoshimatsu, H. Yoshino, and T. Owa (2002)
Mol. Cancer Ther.
1, 275-286
| Abstract »
| Full Text »
| PDF »
- Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening.
- C. M. Grozinger, E. D. Chao, H. E. Blackwell, D. Moazed, and S. L. Schreiber (2001)
J. Biol. Chem.
276, 38837-38843
| Abstract »
| Full Text »
| PDF »
- Macromolecular Therapeutics: Emerging Strategies for Drug Discovery in the Postgenome Era.
- R.L. Juliano, A. Astriab-Fisher, and D. Falke (2001)
Mol. Interv.
1, 40-53
| Abstract »
| Full Text »
- Genetic Information, Genomic Technologies, and the Future of Drug Discovery.
- T. F. Bumol and A. M. Watanabe (2001)
JAMA
285, 551-555
| Abstract »
| Full Text »
| PDF »
- Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic Resistance.
- G. H. Cassell and J. Mekalanos (2001)
JAMA
285, 601-605
| Abstract »
| Full Text »
| PDF »
- Small molecule developmental screens reveal the logic and timing of vertebrate development.
- R. T. Peterson, B. A. Link, J. E. Dowling, and S. L. Schreiber (2000)
PNAS
97, 12965-12969
| Abstract »
| Full Text »
| PDF »
- Examining the Living Genome in Health and Disease With DNA Microarrays.
- M. Diehn, A. A. Alizadeh, and P. O. Brown (2000)
JAMA
283, 2298-2299
| Full Text »
| PDF »
- Harnessing the Power of the Genome in the Search for New Antibiotics.
- J. Rosamond and A. Allsop (2000)
Science
287, 1973-1976
| Abstract »
| Full Text »
|
|